Dysmenorrhea Clinical Trial
Official title:
The Efficacy of Viburnum Opulus 3X in the Treatment of Primary Dysmenorrhea
Dysmenorrhea (painful menstruation) is a common gynaecological disorder that is prevalent in
more than 50% of women during their reproductive years. Primary dysmenorrhea describes
cyclic uterine pain without any identifiable or underlying causes. Menstrual pain results as
a consequence of endometrial ischemia, high levels of prostaglandins and other inflammatory
mediators. Conventional treatment for primary dysmenorrhea consists of non-steroidal
anti-inflammatory drugs and oral contraceptives, which may have adverse effects. Viburnum
opulus (Cramp bark) is a homoeopathic remedy well indicated for the treatment of
dysmenorrhea. While there are studies using Viburnum opulus in its herbal form, there is no
research assessing its efficacy in the homoeopathic form.
The aim of this study is to determine the efficacy of Viburnum opulus 3X in the treatment of
primary dysmenorrhea as measured with the modified Short Form McGill pain questionnaire
(SF-MPQ-2) and visual analogue scale (VAS) respectively.
This will be a double blind placebo controlled study, involving 30 female participants. The
study will run for 3 months, over 3 menstrual cycles and shall be determined by the length
of each participant menstrual cycle. The participants will be assessed over 3 menstrual
events. Consultations will take place in a private setting at the Homoeopathic Health Centre
at the Doornfontein campus, under the supervision of a registered homoeopath.
Participants will be recruited by advertisements placed at the University of Johannesburg
Health Centre located on the Doornfontein campus, with the relevant permission obtained.
The researcher will explain the study to each participant as well as provide each
participant with a consent form to sign, before they may take part in the study.
Participants will be screened and a general physical examination will be conducted to asses
each participant's general wellbeing. Each participant will be issued with a modified Short
Form McGill questionnaire and the Visual Analogue Scale to complete. Participants will be
instructed to complete the forms when they begin to experience the pain and cramping. No
medication will be given at the initial consultation.
During the second follow-up consultation the participants will return their completed forms
given to them at the initial consultation. Each participant will be issued with a 50 ml
bottle of the homoeopathic remedy or placebo and new forms (SF-MPQ-2 and VAS) to complete.
Participants will be advised to take 10 drops of the remedy three times a day starting when
they experience pain and cramping. The forms will additionally need to be completed during
this time. The participants will be advised to stop the homoeopathic remedy when their pain
and cramping has ceased. This process will be repeated at both the third and fourth
consultations.
During the final consultation participants will return the last forms to the researcher. The
participants will measure their subjective satisfaction of the medicine on their pain by
completing the five point treatment satisfaction scale.
The data will be statistically analysed by the researcher with the aid of a statistician.
This will be done using the non-parametric Friedmann test (to measure the differences within
both groups) and the Mann-Whitney test (to measure the differences between the groups) as
well as the repeated measures ANOVA. These tests will evaluate the change of severity of
symptoms over time.
The possible benefits for those participating in the study may include an improvement in
their symptoms of primary dysmenorrhea. This study will contribute to the medical knowledge
and efficacy of the clinical management of primary dysmenorrhea.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04607382 -
Survey on Menstrual Symptoms, Health Related Quality of Life and Work Productivity in Patients Suffering From Pain During Menstruation (Dysmenorrhea) in Japan
|
||
Recruiting |
NCT04091789 -
Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea
|
Phase 2 | |
Completed |
NCT00746096 -
Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary Dysmenorrhea
|
Phase 3 | |
Completed |
NCT00769964 -
VA111913 TS: First in Human Study
|
Phase 1 | |
Completed |
NCT00104546 -
Vitamin K Injections for the Treatment of Painful Menstruation
|
Phase 1 | |
Completed |
NCT06011928 -
MOPEXE and RE in Treating Dysmenorrhea
|
N/A | |
Not yet recruiting |
NCT06398990 -
The Effect of Cognitive Exercise Therapy Approach and Yoga in Adolescents With Dysmenorrhoea
|
N/A | |
Recruiting |
NCT02031523 -
Multi-center Clinical Trials of Sanjie Analgesic Capsule in Treating Endometriosis
|
Phase 4 | |
Completed |
NCT01449305 -
Effectiveness of Nanoone Woman Underwear Using in the Management of Dysmenorrhea
|
N/A | |
Completed |
NCT00995917 -
A Pilot Study of Acupoint Injection for Primary Dysmenorrhea
|
N/A | |
Completed |
NCT02910167 -
Observational Prospective Study to Evaluate AEs, Risk Factors and Drug Utilization of BUSCAPINA COMPOSITUM N in Adults From Metropolitan Lima
|
||
Not yet recruiting |
NCT05461846 -
Effect of Integrated Neuromuscular Inhibition Technique in Females With Menstrual Low Back Pain
|
N/A | |
Completed |
NCT05247333 -
Implementation of a Minor Ailment Service in Community Pharmacy Practice
|
N/A | |
Not yet recruiting |
NCT03697746 -
Comparison of Dexketoprofen, Paracetamol and Ibuprofen in the Treatment of Primary Dysmenorrhea
|
N/A | |
Recruiting |
NCT03394547 -
Pulsed Electromagnetic Field Treatment for Painful Periods
|
N/A | |
Recruiting |
NCT06294743 -
Posterior Tibia Nerve Neuroprolotherapy for Dysmenorrhea
|
Early Phase 1 | |
Active, not recruiting |
NCT01738204 -
The Women's Health Study: From Adolescence to Adulthood
|
||
Completed |
NCT01462370 -
Study to Assess the Safety and Efficacy of Etoricoxib Versus Ibuprofen in the Treatment of Dysmenorrhea (MK-0663-145 AM1)
|
Phase 3 | |
Completed |
NCT01250587 -
Dose-Finding Study of PDC31 in Patients With Primary Dysmenorrhea
|
Phase 1 | |
Completed |
NCT00951561 -
A Comparison Study of Pain Relief From Dysmenorrhea Between the Vipon Tampon and Ibuprofen
|
N/A |